These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31096672)

  • 1. Synthesis, Docking and Biological Evaluation of a Novel Class of Imidazothiazoles as IDO1 Inhibitors.
    Serafini M; Torre E; Aprile S; Massarotti A; Fallarini S; Pirali T
    Molecules; 2019 May; 24(10):. PubMed ID: 31096672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicomponent approach in the discovery of indoleamine 2,3-dioxygenase 1 inhibitors: Synthesis, biological investigation and docking studies.
    Griglio A; Torre E; Serafini M; Bianchi A; Schmid R; Coda Zabetta G; Massarotti A; Sorba G; Pirali T; Fallarini S
    Bioorg Med Chem Lett; 2018 Feb; 28(4):651-657. PubMed ID: 29398544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Molecular Modeling Studies of N'-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Lee DH; Lee JY; Jeong J; Kim M; Lee KW; Jang E; Ahn S; Lee CH; Hwang JY
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29120388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors.
    Peng YH; Liao FY; Tseng CT; Kuppusamy R; Li AS; Chen CH; Fan YS; Wang SY; Wu MH; Hsueh CC; Chang JY; Lee LC; Shih C; Shia KS; Yeh TK; Hung MS; Kuo CC; Song JS; Wu SY; Ueng SH
    J Med Chem; 2020 Feb; 63(4):1642-1659. PubMed ID: 31961685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 5-(N-hydroxycarbamimidoyl) benzofuran derivatives as novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    Jung J; Yoon H; Sohn TI; Jang K; Yoo Y; Jeong I; Shin JE; Lee JH; Ann J; Lee J
    Bioorg Med Chem Lett; 2021 May; 40():127963. PubMed ID: 33741464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
    Tomek P; Palmer BD; Flanagan JU; Sun C; Raven EL; Ching LM
    Eur J Med Chem; 2017 Jan; 126():983-996. PubMed ID: 28011425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomolar potency of imidazo[2,1-b]thiazole analogs as indoleamine 2,3-dioxygenase inhibitors.
    Ewida MA; Ewida HA; Ahmed MS; Allam HA; ElBagary RI; George RF; Georgey HH; El-Subbagh HI
    Arch Pharm (Weinheim); 2021 Nov; 354(11):e2100202. PubMed ID: 34313342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taking advantage of the interaction between the sulfoxide and heme cofactor to develop indoleamine 2, 3-dioxygenase 1 inhibitors.
    Wang Y; Jia S; Chen Y; Liao X; Jie R; Jiang L; Wang T; Wen H; Gan W; Cui H
    Bioorg Chem; 2024 Jul; 148():107426. PubMed ID: 38733750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1.
    Peng YH; Ueng SH; Tseng CT; Hung MS; Song JS; Wu JS; Liao FY; Fan YS; Wu MH; Hsiao WC; Hsueh CC; Lin SY; Cheng CY; Tu CH; Lee LC; Cheng MF; Shia KS; Shih C; Wu SY
    J Med Chem; 2016 Jan; 59(1):282-93. PubMed ID: 26642377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and structure-activity relationship study of novel naphthoindolizine and indolizinoquinoline-5,12-dione derivatives as IDO1 inhibitors.
    Yang R; Chen Y; Pan L; Yang Y; Zheng Q; Hu Y; Wang Y; Zhang L; Sun Y; Li Z; Meng X
    Bioorg Med Chem; 2018 Sep; 26(17):4886-4897. PubMed ID: 30170925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel imidazoles as IDO1 inhibitors through microwave-assisted one-pot multicomponent reactions.
    Bai Z; Huang H; Chen J; Zhang X; Ding Y
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900165. PubMed ID: 31482583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design, synthesis and biological evaluation of ubiquinone derivatives as IDO1 inhibitors.
    Ding Y; Tang F; Xue X; Luo J; Hussain M; Huang Y; Wang Z; Jiang H; Tu Z; Zhang J
    Bioorg Chem; 2019 Aug; 89():102870. PubMed ID: 31103493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to
    Serafini M; Torre E; Aprile S; Grosso ED; Gesù A; Griglio A; Colombo G; Travelli C; Paiella S; Adamo A; Orecchini E; Coletti A; Pallotta MT; Ugel S; Massarotti A; Pirali T; Fallarini S
    J Med Chem; 2020 Mar; 63(6):3047-3065. PubMed ID: 32150677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel IDO1 inhibitors via structure-based virtual screening and biological assays.
    Ge H; Mao L; Zhao J; Wang Y; Shi D; Yang X; Wang X; Liu H; Yao X
    J Comput Aided Mol Des; 2021 May; 35(5):679-694. PubMed ID: 33905074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors.
    Gao D; Li Y
    Bioorg Med Chem; 2017 Jul; 25(14):3780-3791. PubMed ID: 28526475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docking Studies and Molecular Dynamic Simulations Reveal Different Features of IDO1 Structure.
    Greco FA; Bournique A; Coletti A; Custodi C; Dolciami D; Carotti A; Macchiarulo A
    Mol Inform; 2016 Sep; 35(8-9):449-59. PubMed ID: 27546049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis and Biological Evaluation of Novel 1,2,5-Oxadiazol-3- Carboximidamide Derivatives as Indoleamine 2, 3-Dioxygenase 1 (IDO1) Inhibitors.
    Xia Z; Nan Y; Liu C; Lin G; Gu K; Chen C; Zhao W; Ju D; Dong X
    Anticancer Agents Med Chem; 2020; 20(13):1592-1603. PubMed ID: 32496990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy.
    Weng T; Qiu X; Wang J; Li Z; Bian J
    Eur J Med Chem; 2018 Jan; 143():656-669. PubMed ID: 29220788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors.
    Zhou C; Lai F; Sheng L; Chen X; Li Y; Feng Z
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32210078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragment-based approach to identify IDO1 inhibitor building blocks.
    Coletti A; Camponeschi F; Albini E; Greco FA; Maione V; Custodi C; Ianni F; Grohmann U; Orabona C; Cantini F; Macchiarulo A
    Eur J Med Chem; 2017 Dec; 141():169-177. PubMed ID: 29031064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.